FOXP3+ Tregs and B7-H1+/PD-1+T lymphocytes co-infiltrate the tumor tissues of high-risk breast cancer patients: Implication for immunotherapy
Data up to Jan 2025
Total Citations Per Year
Abstract
References (58)
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
2003 • 7,902 citations
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
2004 • 4,872 citations
Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation
2000 • 4,853 citations
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
2002 • 4,625 citations
Conversion of Peripheral CD4+CD25− Naive T Cells to CD4+CD25+ Regulatory T Cells by TGF-β Induction of Transcription Factor Foxp3
2003 • 4,529 citations
Restoring function in exhausted CD8 T cells during chronic viral infection
2005 • 3,743 citations
Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade
2002 • 2,879 citations
CD4+CD25+ Immunoregulatory T Cells Suppress Polyclonal T Cell Activation In Vitro by Inhibiting Interleukin 2 Production
1998 • 2,658 citations
B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion
1999 • 2,380 citations
CD4+CD25high Regulatory Cells in Human Peripheral Blood
2001 • 1,882 citations
Prevalence of Regulatory T Cells Is Increased in Peripheral Blood and Tumor Microenvironment of Patients with Pancreas or Breast Adenocarcinoma
2002 • 1,454 citations
Molecular Definition of Breast Tumor Heterogeneity
2007 • 1,338 citations
Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+T lymphocytes are prognostic factors of human ovarian cancer
2007 • 1,317 citations
Tissue expression of PD-L1 mediates peripheral T cell tolerance
2006 • 1,145 citations
Quantification of Regulatory T Cells Enables the Identification of High-Risk Breast Cancer Patients and Those at Risk of Late Relapse
2006 • 1,118 citations
Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody.
1999 • 1,066 citations
Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells
2005 • 998 citations
Blockade of B7-H1 and PD-1 by Monoclonal Antibodies Potentiates Cancer Therapeutic Immunity
2005 • 972 citations
TGF-β1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells
2005 • 955 citations
Clinical Significance and Therapeutic Potential of the Programmed Death-1 Ligand/Programmed Death-1 Pathway in Human Pancreatic Cancer
2007 • 843 citations
Tumor B7-H1 Is Associated with Poor Prognosis in Renal Cell Carcinoma Patients with Long-term Follow-up
2006 • 826 citations
Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells
2004 • 805 citations
Clinical Significance of Programmed Death-1 Ligand-1 and Programmed Death-1 Ligand-2 Expression in Human Esophageal Cancer
2005 • 758 citations
Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target
2004 • 742 citations
Regulatory T cells in cancer
2006 • 717 citations
B7-H1 Expression on Non-Small Cell Lung Cancer Cells and Its Relationship with Tumor-Infiltrating Lymphocytes and Their PD-1 Expression
2004 • 664 citations
PD-1:PD-L inhibitory pathway affects both CD4+ and CD8+ T cells and is overcome by IL-2
2002 • 646 citations
Human CD4+CD25+ cells: a naturally occurring population of regulatory T cells
2001 • 615 citations
IL-2 administration increases CD4+CD25hi Foxp3+ regulatory T cells in cancer patients
2005 • 602 citations
Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level
2005 • 589 citations
Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy
2004 • 571 citations
The B7-H1 (PD-L1) T Lymphocyte-Inhibitory Molecule Is Expressed in Breast Cancer Patients with Infiltrating Ductal Carcinoma: Correlation with Important High-Risk Prognostic Factors
2006 • 570 citations
PD-1 Is Expressed by Tumor-Infiltrating Immune Cells and Is Associated with Poor Outcome for Patients with Renal Cell Carcinoma
2007 • 527 citations
B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma.
2003 • 481 citations
CD4+CD25high T Cells Are Enriched in the Tumor and Peripheral Blood of Prostate Cancer Patients
2006 • 416 citations
Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma
2006 • 412 citations
Expression of the B7 - related molecule B7 - H1 by glioma cells: a potential mechanism of immune paralysis
2003 • 370 citations
618: Costimulatory B7-H1 In Renal Cell Carcinoma Patients: Indicator of Tumor Aggressiveness and Potential Therapeutic Target
2005 • 358 citations
De novogeneration of antigen-specific CD4+CD25+regulatory T cells from human CD4+CD25–cells
2005 • 284 citations
Conversion of CD4+ CD25− cells into CD4+ CD25+ regulatory T cells in vivo requires B7 costimulation, but not the thymus
2005 • 271 citations
B7-H1 (Programmed Death-1 Ligand) on Dendritic Cells Is Involved in the Induction and Maintenance of T Cell Anergy
2003 • 263 citations
Survival of patients with metastatic breast carcinoma
2003 • 260 citations
PD-1 Regulates Self-Reactive CD8+ T Cell Responses to Antigen in Lymph Nodes and Tissues
2007 • 237 citations
Time-dependence of hazard ratios for prognostic factors in primary breast cancer
1998 • 229 citations
Escape from immunotherapy: possible mechanisms that influence tumor regression/progression
2004 • 179 citations
Cutting Edge: Murine Vascular Endothelium Activates and Induces the Generation of Allogeneic CD4+25+Foxp3+ Regulatory T Cells
2005 • 148 citations
Expression of B7‐H1 in breast cancer patients is strongly associated with high proliferative Ki‐67‐expressing tumor cells
2007 • 146 citations
Strategies of Tumor Immune Evasion
2005 • 144 citations
Involvement of the Programmed Death-1/Programmed Death-1 Ligand Pathway in CD4+CD25+ Regulatory T-Cell Activity to Suppress Alloimmune Responses
2007 • 131 citations
Escape strategies and reasons for failure in the interaction between tumour cells and the immune system: how can we tilt the balance towards immune-mediated cancer control?
2005 • 72 citations
Targeting Molecular and Cellular Inhibitory Mechanisms for Improvement of Antitumor Memory Responses Reactivated by Tumor Cell Vaccine
2007 • 71 citations
Induction of immunosuppressive molecules and regulatory T cells counteracts the antitumor effect of interleukin-12-based gene therapy in a transgenic mouse model of liver cancer
2007 • 69 citations
Phenotyping of lymphocytes expressing regulatory and effector markers in infiltrating ductal carcinoma of the breast
2005 • 66 citations
Programmed death-1–programmed death-L1 interaction is essential for induction of regulatory cells by intratracheal delivery of alloantigen
2004 • 39 citations
Vaccine immunotherapy in breast cancer treatment: promising, but still early
2007 • 39 citations
The Use of FoxP3 as a Biomarker and Prognostic Factor for Malignant Human Tumors
2007 • 24 citations
Induction and maintenance of self tolerance: the role of CD4+CD25+ regulatory T cells
2006 • 11 citations
Responding to the progress in hepatology: beyond the boundaries
2007 • 6 citations